FUJIFILM Biotechnologies

Developing a productive GMP-ready process can be a large hurdle for innovators when they are advancing a microbial-expressed biologic. View this webinar to learn how innovative technology and a history of experience across microbial strains and molecule types can be leveraged to streamline and accelerate microbial process development.

Can AAV manufacturing scale without added cost or risk? Watch this expert interview to discover how FUJIFILM Biotechnologies' viral vector CDMO builds process robustness from day one, helping reduce cost per dose at 2,000 L while maintaining quality and enabling commercial readiness.

We have opened our new 2,000 m2 quality control laboratory at our commercial manufacturing site in Hillerød. The lab expands bioassay and virology capacity to meet demand and support our growth to 20 × 20,000 L bioreactors. Designed for flexibility, it includes modern ventilation, airlocks, and an open plan, supports about 100 quality professionals, and incorporates robotics and a global LIMS. Housed in a new building with enhanced amenities and an emergency generator, the lab received DKMA approval in March and begins operations in May. Read more: https://brnw.ch/21x1Cy5 #Hillerød #QualityControl #KojoX #CDMO

We are honored to be named a finalist for Fierce Biotech's 2026 Outsourcing Awards in the category of Supply Chain Excellence. This recognition reflects the dedication of our teams and partners who work every day to build resilient, reliable, and transparent supply networks that support patients and customers. Thank you to Fierce, and to our colleagues across sites for the discipline, collaboration, and care that make this possible. Learn more here: https://brnw.ch/21x1rav #FiercePharma #Outsourcing #SupplyChain #Biomanufacturing #CDMO #OperationalExcellence

FUJIFILM Biotechnologies has been named a winner in the CDMO Leadership Awards for Most Innovative CDMO (Biologics), an honor grounded in direct sponsor feedback from the past 18–24 months. This distinction underscores our continued investment in science, analytics, and process development to support our partners from early development through commercialization and built on Fujifilm’s 90+ year legacy in healthcare innovation. Most importantly, they recognize the outcomes our teams deliver: smarter development, stronger analytics, and reliable manufacturing. Thank you to our partners for your trust. Our success is driven by collaboration, transparency, and a shared commitment to be Partners for Life. Learn more here: https://brnw.ch/21x14C9 #CDMOLeadershipAwards #Innovation #Biologics #CellAndGeneTherapy #AnalyticalServices #CDMO #PartnersForLife #FUJIFILMBiotechnologies

From film to the future of medicine. In a little over a decade, FUJIFILM Biotechnologies has evolved from a bold bet into a global biomanufacturing force, opening a landmark facility in Holly Springs, North Carolina, and building a network designed for speed, reliability, and scale. CEO Lars Petersen sits down with Chief Executive Group to share how an $8B+ investment, a novel kojoX manufacturing philosophy, and trust‑based partnerships are rewriting what a CDMO can be. Curious how a 90‑year‑old heritage photo brand transformed to became one of biomanufacturing's most dynamic leaders? Read the full story: https://lnkd.in/e_xNskE8 #Biomanufacturing #CDMO #Innovation #HollySprings #KojoX #Leadership #LifeSciences